Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Collegium Pharmaceutical, Inc. (NASDAQ: COLL).

Full DD Report for COLL

You must become a subscriber to view this report.


Recent News from (NASDAQ: COLL)

FDA OKs first non-opioid treatment for opioid withdrawal
The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read ...
Source: SeekingAlpha
Date: May, 16 2018 16:44
Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks
Stock Research Monitor: AKRX, COLL, and LPCN LONDON, UK / ACCESSWIRE / May 11, 2018 / If you want a free Stock Review on HZNP sign up now at www.wallstequities.com/registration . WallStEquities.com features the Generic Drugs market, which can be segmented into biosimilars, simple ...
Source: ACCESSWIRE IA
Date: May, 11 2018 07:00
Collegium Pharmaceutical's (COLL) CEO Michael Heffernan on Q1 2018 Results - Earnings Call Transcript
Collegium Pharmaceutical (COLL) Q1 2018 Results Earnings Conference Call May 09, 2018, 04:30 PM ET Executives Joseph Ciaffoni - Executive VP & COO Michael Heffernan - Founder, Chairman, President, CEO, Treasurer & Secretary Paul Brannelly - Executive VP, CFO & Princip...
Source: SeekingAlpha
Date: May, 09 2018 23:14
Collegium Pharmaceutical misses by $0.08, beats on revenue
Collegium Pharmaceutical (NASDAQ: COLL ): Q1 EPS of -$0.57 misses by $0.08 . More news on: Collegium Pharmaceutical, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 09 2018 16:07
Collegium to Present at the Deutsche Bank Health Care Conference
CANTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the Deutsche Bank 43 rd Annual Health Care Conference on Tuesday, May 8, 2018 at 12:50 p.m. ET at the Intercontinental Hotel Boston. Abou t Coll...
Source: GlobeNewswire
Date: May, 02 2018 16:01
Opioid prescriptions dropped 12% in 2017
Opioid prescriptions dropped 12% in 2017, according to a report from the IQVIA Institute for Human Data Science. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 26 2018 03:18
Investor Expectations to Drive Momentum within WESCO International, Microchip Technology, Collegium Pharmaceutical, Actuant, Toro, and Expeditors International of Washington - Discovering Underlying Factors of Influence
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of WESCO International, Inc. (NYSE:WCC), Microchip Technology Incorporated ...
Source: GlobeNewswire
Date: April, 23 2018 07:45
Collegium to Host Conference Call to Discuss First Quarter 2018 Financial Results and Provide Corporate Update
CANTON, Mass., April 20, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, May 9, 2018 at 4:30 p.m. Eastern Time.  The Company will discuss its financial results and pr...
Source: GlobeNewswire
Date: April, 20 2018 08:01
Collegium to Present at the H.C. Wainwright Global Life Sciences Conference
CANTON, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 11:55 a.m. CET at Le Meridien Beach Plaza Hotel in Monte Carlo, Mo...
Source: GlobeNewswire
Date: April, 04 2018 16:01
Depomed Distances Itself From Nucynta
Source: primerxmart.com The opioid crisis has gained national attention over the past year and lawmakers are fighting back. President Trump called it a "national crisis" and is looking for ways to tamp down the number opioid prescriptions. Mallinckrodt ( MNK ) tried to sell its unit that m...
Source: SeekingAlpha
Date: March, 27 2018 08:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1724.5725.2025.3324.19287,938
2017-02-0316.1215.7016.17515.43292,908
2017-02-0216.9516.1017.0315.98400,797
2017-02-0117.0016.9917.6016.71307,569
2017-01-3116.0416.8216.9015.81178,373

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1597,841169,63857.6763Short
2018-08-1495,415130,53273.0970Short
2018-08-1382,326145,93056.4147Short
2018-08-10150,746259,80958.0219Short
2018-08-09257,109437,00358.8346Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on COLL.


About Collegium Pharmaceutical, Inc. (NASDAQ: COLL)

Logo for Collegium Pharmaceutical, Inc. (NASDAQ: COLL)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $833,425,762 - 05/15/2018
  • Issue and Outstanding: 32,993,894 - 03/01/2018

 


Recent Filings from (NASDAQ: COLL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 18 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 13 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 07 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 07 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: February, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 22 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: COLL)

Daily Technical Chart for (NASDAQ: COLL)


Stay tuned for daily updates and more on (NASDAQ: COLL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: COLL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in COLL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of COLL and does not buy, sell, or trade any shares of COLL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/